Our study indicated that patients with limited BMs in the upfront TKI group were more likely to develop meningeal metastases and multiple BMs at the first cranial progression during the treatment of EGFR-TKIs and thus losing the opportunity of SRS in salvage RT. This evidence concerns the gene EGFR and infectious meningitis.